From March 22ndto 24th, 2025, the 22nd China Association of Clinical Laboratory Practice Expo (CACLP) was grandly held at the Hangzhou Grand Convention & Exhibition Center. As an influential industry event in the field of in vitro diagnostics, this event attracted more than 1,200 enterprises to participate.

Illumax's chemiluminescence system (Lumilite8 / Lumiflx16 / A6m) and multiplex immunoassay system (P8 / P16 / P96) series products have long been well-known in the industry for their excellent and stable performance. The two series of products are divided into semi-automatic and fully automatic, providing more choices for clinical use. Since the launch of the products, illumax has continued to optimize product performance and continuously expand the test menu to provide users with more accurate and comprehensive detection solutions.

At the illumax’s booth, visitors stopped to communicate, overseas customers flocked in, and the atmosphere was warm, fully demonstrating illumax's brand strength and market influence.

The highlight of this exhibition is the first multi-mode immunoassay integrated machine launched by illumax. One instrument can complete chemiluminescence, multiplex immunoassay and flow cytometry, with a maximum configuration of 2 lasers and 6 colors. Compared with the integrated machines launched on the market, illumax’s X100 and X16 are mini in size and fully functional, with supporting reagents covering cardiac markers, inflammation, cytokines, and lymphocyte subpopulation. Cytokine detection can support whole blood, serum, and plasma, greatly improving the detection efficiency and standing out from a number of competing products.